Cadila Healthcare Limited has informed the Exchange regarding a press release dated April 23, 2021, titled "Zydus receives Emergency Use Approval from DCGI for the use of Pegylated Interferon alpha-2b, Virafin in treating moderate COVID-19 infection in adults".
Press Release Apr 23 2021
Filed with NSE · · 3 pages · English
Release
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Apr 08 2021
- Press Release Apr 05 2021
- Press Release Mar 25 2021
- Press Release Mar 24 2021
- Press Release Feb 25 2021
Later from Zydus Lifesciences
- Press Release May 12 2021
- Press Release May 24 2021
- Press Release May 26 2021
- Press Release May 27 2021
- Press Release May 28 2021
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences